Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis

被引:18
作者
Lin, SM
Yeh, JH
Lee, CC
Chiu, HC
机构
[1] Shin Kong Wu Ho Su Mem Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[2] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan
关键词
double filtration plasmapheresis; von Willebrand factor; plasma exchange; coagulopathy; hypofibrinogenemia;
D O I
10.1002/jca.10052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Double filtration plasmapheresis (DFP) is a widely used and effective way to clear autoantibodies from plasma. It can, however, transiently alter the hemostatic system and cause a bleeding tendency in some patients. There is limited data on the consecutive effect of serial DFP on the hemostatic system, especially on fibrinoizen and von Willebrand factor (vWF) levels. This study measured fibrinogen and vWF serially before and after each session of DFP in 8 patients who received one course of DFP treatment for 3 to 5 consecutive sessions on an alternate-day basis. In each session of DFP, the clearance rate of fibrinogen and vWF exceeded 63 and 45%. respectively. The final levels of fibrinogen and vWF after a full course of DFP were reduced to 14.3 and 51.2% of baseline level, respectively. No bleeding tendency was observed in any of the 34 DFP sessions. In conclusion, although an obvious decrease in fibrinogen level and the modest decrease in vWF were observed after an intensive course of DFP treatment, the low incidence of clinically important bleeding confirms the hemostasis-related safety of DFP. (C) 2003 Wiley-Liss. Inc.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 16 条
[1]  
Bithell T.C., 1993, Wintrobe's Clinical Hematology, P566
[2]   Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans [J].
Borchiellini, A ;
Fijnvandraat, K ;
tenCate, JW ;
Pajkrt, D ;
vanDeventer, SJH ;
Pasterkamp, G ;
MeijerHuizinga, F ;
ZwartHuinink, L ;
Voorberg, J ;
vanMourik, JA .
BLOOD, 1996, 88 (08) :2951-2958
[3]  
CHIRNSIDE A, 1981, BRIT J HAEMATOL, V48, P627
[4]  
GILL JC, 1987, BLOOD, V69, P1691
[5]   COAGULATION ABNORMALITIES PRODUCED BY PLASMA-EXCHANGE ON THE CELL SEPARATOR WITH SPECIAL REFERENCE TO FIBRINOGEN AND PLATELET LEVELS [J].
KELLER, AJ ;
CHIRNSIDE, A ;
URBANIAK, SJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 42 (04) :593-603
[6]   Frequency of immediate adverse effects associated with therapeutic apheresis [J].
McLeod, BC ;
Sniecinski, I ;
Ciavarella, D ;
Owen, H ;
Price, TH ;
Randels, MJ ;
Smith, JW .
TRANSFUSION, 1999, 39 (03) :282-288
[7]   THERAPEUTIC PLASMA-EXCHANGE - COMPLICATIONS AND MANAGEMENT [J].
MOKRZYCKI, MH ;
KAPLAN, AA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (06) :817-827
[8]  
ORLIN JB, 1980, BLOOD, V56, P1055
[9]  
OVER J, 1981, J LAB CLIN MED, V97, P332
[10]  
SADLER JE, 2001, MOL BASIS BLOOD DIS, P680